Vascular Biogenics
(NASDAQ:VBLT)
$0.1435
-0.0045[-3.04%]
Last update: 1:09PM (Delayed 15-Minutes)
Get Real Time Here
Day Range0.14 - 0.1552 Wk Range0.11 - 2.2Open / Close0.15 / -Float / Outstanding58.7M / 69.8M
Vol / Avg.812.9K / 1.5MMkt Cap10MP/E-50d Avg. Price0.14
Div / Yield-Payout Ratio-Total Float58.7MEPS-0.12

Vascular Biogenics Stock (NASDAQ:VBLT), Quotes and News Summary

Vascular Biogenics Stock (NASDAQ: VBLT) stock price, news, charts, stock research, profile.

Loading...
Day Range0.14 - 0.1552 Wk Range0.11 - 2.2Open / Close0.15 / -Float / Outstanding58.7M / 69.8M
Vol / Avg.812.9K / 1.5MMkt Cap10MP/E-50d Avg. Price0.14
Div / Yield-Payout Ratio-Total Float58.7MEPS-0.12
Globe Newswire - Aug 2, 2022, 8:00AM
InvestorPlace - Jul 20, 2022, 11:55AM
Seeking Alpha - May 16, 2022, 12:42PM
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.110-0.120 -0.0100
REV200.000K481.000K281.000K
Q2 2022Est.ActualSurprise
EPS-0.130-0.120 0.0100
REV1.400M64.000K-1.336M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Vascular Biogenics (VBLT) stock?

A

You can purchase shares of Vascular Biogenics (NASDAQ: VBLT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vascular Biogenics's (VBLT) competitors?

A

There are no as such competitors for Vascular Biogenics.

Q

What is the target price for Vascular Biogenics (VBLT) stock?

A

The latest price target for Vascular Biogenics (NASDAQ: VBLT) was reported by Chardan Capital on Thursday, July 21, 2022. The analyst firm set a price target for 0.00 expecting VBLT to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vascular Biogenics (VBLT)?

A

The stock price for Vascular Biogenics (NASDAQ: VBLT) is $0.1435 last updated Today at November 28, 2022, 6:09 PM UTC.

Q

Does Vascular Biogenics (VBLT) pay a dividend?

A

There are no upcoming dividends for Vascular Biogenics.

Q

When is Vascular Biogenics (NASDAQ:VBLT) reporting earnings?

A

Vascular Biogenics’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q

Is Vascular Biogenics (VBLT) going to split?

A

There is no upcoming split for Vascular Biogenics.

Q

What sector and industry does Vascular Biogenics (VBLT) operate in?

A

Vascular Biogenics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.